These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 9437199

  • 21. Enhanced association of platelet-activating factor acetylhydrolase with lipoprotein (a) in comparison with low density lipoprotein.
    Blencowe C, Hermetter A, Kostner GM, Deigner HP.
    J Biol Chem; 1995 Dec 29; 270(52):31151-7. PubMed ID: 8537378
    [Abstract] [Full Text] [Related]

  • 22. The contribution of individual lipoproteins to the degradation of platelet-activating factor in human serum.
    Ostermann G, Kostner GM, Gries A, Malle E, Till U.
    Haemostasis; 1989 Dec 29; 19(3):160-8. PubMed ID: 2744632
    [Abstract] [Full Text] [Related]

  • 23. Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma.
    Stafforini DM, Carter ME, Zimmerman GA, McIntyre TM, Prescott SM.
    Proc Natl Acad Sci U S A; 1989 Apr 29; 86(7):2393-7. PubMed ID: 2928339
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase.
    Tselepis AD, John Chapman M.
    Atheroscler Suppl; 2002 Dec 29; 3(4):57-68. PubMed ID: 12573364
    [Abstract] [Full Text] [Related]

  • 26. High-density lipoprotein inhibits the production of platelet activating factor acetylhydrolase by HepG2 cells.
    Satoh K, Imaizumi T, Yoshida H, Takamatsu S.
    J Lab Clin Med; 1994 Feb 29; 123(2):225-31. PubMed ID: 8301198
    [Abstract] [Full Text] [Related]

  • 27. The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease.
    Lourida ES, Papathanasiou AI, Goudevenos JA, Tselepis AD.
    Prostaglandins Leukot Essent Fatty Acids; 2006 Aug 29; 75(2):117-26. PubMed ID: 16843649
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma.
    Subramanian VS, Goyal J, Miwa M, Sugatami J, Akiyama M, Liu M, Subbaiah PV.
    Biochim Biophys Acta; 1999 Jul 09; 1439(1):95-109. PubMed ID: 10395969
    [Abstract] [Full Text] [Related]

  • 32. Platelet-activating factor acetylhydrolase activity in bovine seminal plasma.
    Parks JE, Hough SR.
    J Androl; 1993 Jul 09; 14(5):335-9. PubMed ID: 8288488
    [Abstract] [Full Text] [Related]

  • 33. Lipid peroxidation in low density lipoproteins from human plasma and egg yolk promotes accumulation of 1-acyl analogues of platelet-activating factor-like lipids.
    Tokumura A, Toujima M, Yoshioka Y, Fukuzawa K.
    Lipids; 1996 Dec 09; 31(12):1251-8. PubMed ID: 8972457
    [Abstract] [Full Text] [Related]

  • 34. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.
    Heery JM, Kozak M, Stafforini DM, Jones DA, Zimmerman GA, McIntyre TM, Prescott SM.
    J Clin Invest; 1995 Nov 09; 96(5):2322-30. PubMed ID: 7593619
    [Abstract] [Full Text] [Related]

  • 35. Synergism between platelet-activating factor-like phospholipids and peroxisome proliferator-activated receptor gamma agonists generated during low density lipoprotein oxidation that induces lipid body formation in leukocytes.
    de Assis EF, Silva AR, Caiado LF, Marathe GK, Zimmerman GA, Prescott SM, McIntyre TM, Bozza PT, de Castro-Faria-Neto HC.
    J Immunol; 2003 Aug 15; 171(4):2090-8. PubMed ID: 12902515
    [Abstract] [Full Text] [Related]

  • 36. Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and reduced lipoprotein-associated platelet-activating factor acetylhydrolase activity.
    Tselepis AD, Elisaf M, Besis S, Karabina SA, Chapman MJ, Siamopoulou A.
    Arthritis Rheum; 1999 Feb 15; 42(2):373-83. PubMed ID: 10025933
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Increased activity of the platelet-activating factor acetylhydrolase in plasma low density lipoprotein from patients with essential hypertension.
    Satoh K, Imaizumi T, Kawamura Y, Yoshida H, Takamatsu S, Takamatsu M.
    Prostaglandins; 1989 Jun 15; 37(6):673-82. PubMed ID: 2772220
    [Abstract] [Full Text] [Related]

  • 39. Susceptibility of phospholipids of oxidizing LDL to enzymatic hydrolysis modulates uptake by P388D1 macrophage-like cells.
    Fyrnys B, Blencowe C, Deigner HP.
    FEBS Lett; 1995 Jan 02; 357(1):7-12. PubMed ID: 8001682
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.